20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Cerebral Ischemia in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.55) | 18.2507 |
2000's | 7 (31.82) | 29.6817 |
2010's | 14 (63.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Booz, GW; Cunningham, MW; Fan, F; Pabbidi, MR; Shekhar, S; Wang, S | 1 |
Cheng, G; Li, J; Li, Y; Li, Z; Liu, Y; Lu, L; Teng, G; Zhan, M | 1 |
Attwell, D; Buchan, AM; Gesslein, B; Hall, CN; Hamilton, NB; Lauritzen, M; Mishra, A; O'Farrell, FM; Reynell, C; Sutherland, BA | 1 |
Ergul, A; Hoda, MN; Li, W; Luo, P; Maddipati, KR; Seki, T; Wang, MH; Zhang, Y; Zheng, X | 1 |
Alkayed, NJ; Anderson, VC; Borkar, RN; Cetas, JS; Dogan, A; Fairbanks, SL; Liu, JJ; Martini, RP; Nelson, JW; Raskin, JS; Siler, DA; Wang, RK; Ward, JP; Zuloaga, KL | 1 |
Chen, H; Li, J; Liao, D; Wang, C; Wu, L; Yi, X | 1 |
Liao, D; Lin, J; Yi, X; Zhang, B; Zhou, Q | 1 |
Liao, D; Wang, C; Wu, L; Yi, X; Zhang, B | 1 |
Han, Z; Lin, J; Liu, P; Yi, X; Zhou, Q | 1 |
Lin, J; Wang, C; Yi, X; Zhou, Q | 1 |
Almgren, P; Berglund, G; Engström, G; Fava, C; Hedblad, B; Lippi, G; Melander, O; Minuz, P; Montagnana, M; Rosberg, L | 1 |
Cao, S; Harder, DR; Koehler, RC; Kwansa, H; Roman, RJ; Wang, LC | 1 |
Eto, K; Marumo, T; Nabekura, J; Omura, T; Wake, H | 1 |
Balzer, J; Bender, C; Crago, EA; Horowitz, M; Kuo, CW; Poloyac, SM; Sherwood, PR; Thampatty, BP | 1 |
Carter, EL; Crafa, DA; Harder, DR; Kibler, KK; Koehler, RC; Kwansa, H; Martin, LJ; Roman, RJ; Yang, ZJ | 1 |
Ago, Y; Baba, A; Chaki, S; Doi, H; Hashimoto, H; Kawasaki, T; Marumo, T; Matsuda, T; Mori, T; Nakazato, A; Onoe, H; Shirakami, K; Suzuki, M; Watanabe, Y | 1 |
Cambj-Sapunar, L; Harder, DR; Roman, RJ; Yu, M | 1 |
Kerr, ME; Poloyac, SM; Reynolds, RB; Yonas, H | 1 |
Bies, RR; Graham, SH; Kochanek, PM; Poloyac, SM; Zhang, Y | 1 |
Fukasawa, M; Hachiuma, K; Harder, DR; Koizumi, C; Minagawa, T; Miyata, N; Nakaike, S; Okuyama, S; Omura, T; Roman, RJ; Sakurai, T; Susumu, T; Tanaka, Y; Yoshida, S | 1 |
Fukasawa, M; Horiuchi, N; Minagawa, T; Miyata, N; Nakaike, S; Omura, T; Tanaka, Y; Yoshida, S | 1 |
Balazy, M; Bednar, MM; Falck, JR; Gross, CE | 1 |
1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cerebral Ischemia
Article | Year |
---|---|
Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Endothelial Cells; Genetic Therapy; Humans; Hydroxyeicosatetraenoic Acids; Hyperbaric Oxygenation; Immunomodulation; Inflammation; Macrophages; Microglia; MicroRNAs; Neuroprotective Agents; Oligonucleotides; Oxidative Stress; Signal Transduction; Stroke | 2018 |
21 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cerebral Ischemia
Article | Year |
---|---|
Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
Topics: Angiogenesis Inducing Agents; Animals; Astrocytes; Brain Ischemia; Cell Proliferation; Cytochrome P-450 CYP4A; Disease Models, Animal; Endothelial Cells; Hydroxyeicosatetraenoic Acids; Male; Mice; Mice, Inbred C57BL; Microcirculation; Neovascularization, Pathologic; Stroke; Vascular Endothelial Growth Factor A | 2019 |
Capillary pericytes regulate cerebral blood flow in health and disease.
Topics: Animals; Arterioles; Blood-Brain Barrier; Brain Ischemia; Capillaries; Cell Death; Cerebellum; Cerebral Cortex; Cerebrovascular Circulation; Dinoprostone; Excitatory Amino Acid Antagonists; Female; Functional Neuroimaging; Glutamic Acid; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Pericytes; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Glutamate; Signal Transduction; Stroke; Vasoconstriction; Vasodilation | 2014 |
Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Ischemia; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 CYP4A; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; Lactones; Male; Mice; Mice, Inbred C57BL; Rats; Stroke; Sulfones; Time Factors; Tumor Burden | 2014 |
Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage.
Topics: 8,11,14-Eicosatrienoic Acid; Aged; Animals; Brain Ischemia; Disease Models, Animal; Female; Humans; Hydroxyeicosatetraenoic Acids; Male; Mice; Middle Aged; Neuroprotective Agents; Subarachnoid Hemorrhage | 2015 |
CYP Genetic Variants, CYP Metabolite Levels, and Symptomatic Carotid Stenosis in Ischemic Stroke Patients.
Topics: Aged; Arachidonic Acids; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cytochrome P-450 Enzyme System; Epoxide Hydrolases; Female; Genetic Variation; Genotype; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk; Stroke; Ultrasonography | 2016 |
Interaction Between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level.
Topics: Aged; Brain Ischemia; Case-Control Studies; Cytochrome P-450 CYP4A; Cytochrome P450 Family 4; Epistasis, Genetic; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Polymorphism, Single Nucleotide; Stroke | 2016 |
Interactions Among CYP2C8, EPHX2, and CYP4A11 Variants and CYP Plasma Metabolite Levels in Ischemic Stroke.
Topics: Aged; Biomarkers; Brain Ischemia; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP4A; Epoxide Hydrolases; Female; Follow-Up Studies; Genetic Variation; Genotype; Humans; Hydroxyeicosatetraenoic Acids; Male; Prognosis; Stroke | 2016 |
20-Hydroxyeicosatetraenoic Acid as a Predictor of Neurological Deterioration in Acute Minor Ischemic Stroke.
Topics: Brain Ischemia; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Prognosis; Prospective Studies; Stroke | 2016 |
CYP Genetic Variants, CYP Metabolite Levels, and Neurologic Deterioration in Acute Ischemic Stroke in Chinese Population.
Topics: Aged; Aged, 80 and over; Asian People; Biomarkers; Brain Ischemia; Chi-Square Distribution; China; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Eicosanoids; Epoxide Hydrolases; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Nerve Degeneration; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Stroke; Time Factors | 2017 |
The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure.
Topics: Analysis of Variance; Anthropometry; Brain Ischemia; Cohort Studies; Cytochrome P-450 CYP4A; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Polymorphism, Genetic; Probability; Proportional Hazards Models; Sex Factors; Stroke | 2008 |
Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion.
Topics: Amidines; Animals; Arterioles; Blood Substitutes; Blood Transfusion; Brain Ischemia; Endothelin A Receptor Antagonists; Endothelins; Hemoglobins; Hydroxyeicosatetraenoic Acids; Male; Models, Animal; Oligopeptides; Pia Mater; Polymers; Rats; Rats, Wistar; Regional Blood Flow; Vasodilation | 2009 |
The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice.
Topics: Animals; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Formamides; Homeostasis; Hydroxyeicosatetraenoic Acids; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Microcirculation; Morpholines | 2010 |
Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage.
Topics: Adolescent; Adult; Aged; Brain Ischemia; Cerebrovascular Circulation; Female; Humans; Hydroxyeicosatetraenoic Acids; Male; Microcirculation; Middle Aged; Neuropsychological Tests; Subarachnoid Hemorrhage; Treatment Outcome; Ultrasonography, Doppler | 2011 |
Attenuation of neonatal ischemic brain damage using a 20-HETE synthesis inhibitor.
Topics: Amidines; Animals; Animals, Newborn; Brain Ischemia; Hydroxyeicosatetraenoic Acids; Infusions, Intraventricular; Male; Swine | 2012 |
Increase of 20-HETE synthase after brain ischemia in rats revealed by PET study with 11C-labeled 20-HETE synthase-specific inhibitor.
Topics: Animals; Autoradiography; Brain Ischemia; Carbon Radioisotopes; Cytochrome P-450 CYP4A; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Hydroxyeicosatetraenoic Acids; Imidazoles; Immunohistochemistry; Isotope Labeling; Longitudinal Studies; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution | 2012 |
Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage.
Topics: Amidines; Animals; Blood; Brain Ischemia; Calcium Signaling; Cerebrospinal Fluid; Cerebrovascular Circulation; Cisterna Magna; Eicosanoic Acids; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Injections; Male; Middle Cerebral Artery; Muscle, Smooth, Vascular; Phospholipases A; Propanolamines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Subarachnoid Hemorrhage; Vascular Resistance; Vasoconstriction; Vasospasm, Intracranial | 2003 |
Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Aged; Arachidonic Acid; Brain Ischemia; Cerebral Arteries; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Humans; Hydroxyeicosatetraenoic Acids; Mass Spectrometry; Middle Aged; Neurochemistry; Subarachnoid Hemorrhage; Time Factors; Vasospasm, Intracranial | 2005 |
Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia.
Topics: Amidines; Animals; Brain Injuries; Brain Ischemia; Cerebrovascular Circulation; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Male; Microsomes; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; Vasoconstriction | 2006 |
Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury.
Topics: Animals; Brain Ischemia; Dose-Response Relationship, Drug; Formamides; Gas Chromatography-Mass Spectrometry; Haplorhini; Hydroxyeicosatetraenoic Acids; Male; Morpholines; Rats; Rats, Wistar; Reperfusion Injury | 2006 |
Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.
Topics: Animals; Brain; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Formamides; Hydroxyeicosatetraenoic Acids; Ischemic Attack, Transient; Morpholines; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Treatment Outcome; Up-Regulation; Vasodilation | 2007 |
Antineutrophil strategies.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Cell Adhesion; Cerebrovascular Disorders; Humans; Hydroxyeicosatetraenoic Acids; Leukocyte Count; Middle Aged; Neutrophil Activation; Neutrophils | 1997 |